The Kinase PDK1 Is Essential for B-Cell Receptor Mediated Survival Signaling

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Park, Sung Gyoo ^a,b   Long, Meixiao ^a   Kang, Jung Ah ^b   Kim, Woo Seok ^b   Lee, Cho Rong ^b   Im, Sin Hyeog ^b   Strickland, Ian ^a   Schulze Luehrmann, Jan ^a   Hayden, Matthew S ^a   Ghosh, Sankar ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN M; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; TRANSCRIPTION FACTOR FOXO;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL ASSAY; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE DELETION; INTRACELLULAR SIGNALING; LYMPHOCYTE COUNT; MOUSE; MUTATOR GENE; NONHUMAN; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1 GENE; PRE B LYMPHOCYTE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MICE; NF-KAPPA B; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANTIGEN, B-CELL;

EID: 84873487984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055378     Document Type: Article

References (33)

1. Lawlor MA, Mora A, Ashby PR, Williams MR, Murray-Tait V, et al. (2002) Essential role of PDK1 in regulating cell size and development in mice. EMBO J 21: 3728-3738.
2. Bayascas JR, Wullschleger S, Sakamoto K, Garcia-Martinez JM, Clacher C, et al. (2008) Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance. Mol Cell Biol 28: 3258-3272.
3. Mora A, Komander D, van Aalten DM, Alessi DR, (2004) PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 15: 161-170.
4. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, et al. (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science. 279: 710-714.
5. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, et al. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7: 261-269.
6. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM, (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
7. Hresko RC, Mueckler M, (2005) mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem 280: 40406-40416.
8. Park SG, Schulze-Luehrman J, Hayden MS, Hashimoto N, Ogawa W, et al. (2009) The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells. Nat Immunol 10: 158-166.
9. Hinton HJ, Alessi DR, Cantrell DA, (2004) The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development. Nat Immunol 5: 539-545.
10. Kurosaki T, (2002) Regulation of B cell fates by BCR signaling components. Curr Opin Immunol 14: 341-347.
11. Suzuki H, Matsuda S, Terauchi Y, Fujiwara M, Ohteki T, et al. (2003) PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat Immunol 4: 280-286.
12. Donahue AC, Fruman DA, (2004) PI3K signaling controls cell fate at many points in B lymphocyte development and activation. Semin Cell Dev Biol 15: 183-197.
13. Schulze-Luehrmann J, Ghosh S, (2006) Antigen-receptor signaling to nuclear factor kappa B. Immunity. 25: 701-715.
14. Patke A, Mecklenbrauker I, Tarakhovsky A, (2004) Survival signaling in resting B cells. Curr Opin Immunol 16: 251-255.
15. Hess KL, Donahue AC, Ng KL, Moore TI, Oak J, et al. (2004) Frontline: The p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses. Eur J Immunol 34: 2968-2976.
16. Su TT, Guo B, Kawakami Y, Sommer K, Chae K, et al. (2002) PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol 3: 780-786.
17. Sommer K, Guo B, Pomerantz JL, Bandaranayake AD, Moreno-Garcia ME, et al. (2005) Phosphorylation of the CARMA1 linker controls NF-kappaB activation. Immunity 23: 561-574.
18. Shinohara H, Yasuda T, Aiba Y, Sanjo H, Hamadate M, et al. (2005) PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1. J Exp Med 202: 1423-1431.
19. Kloo B, Nagel D, Pfeifer M, Grau M, Duwel M,et al. Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells. Proc Natl Acad Sci U S A 108: 272-277.
20. Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, et al. (1999) Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 283: 390-392.
21. Fruman DA, Snapper SB, Yballe CM, Davidson L, Yu JY, et al. (1999) Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 283: 393-397.
22. Sasaki Y, Schmidt-Supprian M, Derudder E, Rajewsky K, (2007) Role of NFkappaB signaling in normal and malignant B cell development. Adv Exp Med Biol 596: 149-154.
23. Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
24. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G, (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689.
25. Mok CL, Gil-Gomez G, Williams O, Coles M, Taga S, et al. (1999) Bad can act as a key regulator of T cell apoptosis and T cell development. J Exp Med 189: 575-586.
26. Srinivasan L, Sasaki Y, Calado DP, Zhang B, Paik JH, et al. (2009) PI3 kinase signals BCR-dependent mature B cell survival. Cell 139: 573-586.
27. Rickert RC, Roes J, Rajewsky K, (1997) B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res 25: 1317-1318.
28. Hashimoto N, Kido Y, Uchida T, Asahara S, Shigeyama Y, et al. (2006) Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat Genet 38: 589-593.
29. Schriever F, Freedman AS, Freeman G, Messner E, Lee G, et al. (1989) Isolated human follicular dendritic cells display a unique antigenic phenotype. J Exp Med 169: 2043-2058.
30. Hayashi T, Mo JH, Gong X, Rossetto C, Jang A, et al. (2007) 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Proc Natl Acad Sci U S A 104: 18619-18624.
31. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, et al. (1996) Immunodeficiency in protein kinase cbeta-deficient mice. Science 273: 788-791.
32. Hara H, Wada T, Bakal C, Kozieradzki I, Suzuki S, et al. (2003) The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18: 763-775.
33. Yusuf I, Zhu X, Kharas MG, Chen J, Fruman DA, (2004) Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 104: 784-787.